CH / EN
Company Profile

Founded in 2019, Kai Medtech specializes in the research, manufacture and merchandise of neurovascular interventional medical consumables.
Kai's product pipeline includes hemorrhagic apoplexy, acute ischemia and chronic ischemia products.

Taking neurovascular as the breakthrough point, equipped with two-wheel drive--strong independent innovation capability + advanced global BD introduction capacity, along with perfect closed-loop system of innovation-consumables-marketing, our company devote to becoming a leading innovation technology platform in the global cerebrovascular disease equipment industry, and even the whole medical equipment industry.

Unique "self-innovation+ license BD" platform mode
Strong technology development capability combined with abundant external resources, we will build a global-platform based enterprise and achieve fine complementarity.
With scarce ability of "R&D from scratch" in the industry, as well as the platform positioning of multi-products and cross-specialties, Kai Medtech will acquire unique dislocation competitive advantages.
Experienced and
full-functional core team
The founders and core teams come from top enterprises in the industry, and have many years of experience in underlying technology development, new technology introduction, product registration, marketing and team management. The whole team has functions of all parts and cooperates synergistically.
Global layout brings
leading project resources
Team cooperation between China and the United States not only achieves leading position for early products, but also endows products with global registration and sales capability.
At the same time, excellent overseas BD resources also lay a solid foundation for long-term development.
Plentiful and comprehensive
product strategy + top finance fund
With neurovascular as the starting point, Kai MedTech is committed to build a fully-covered and fast-renewed product pipeline strategy, so as to achieve sustained and stable market increase/coverage. As in the long term, Kai expects to grow into an integrated technology innovation platform for interdisciplinary medical consumables and instruments.

Strong finance support from big funds such as Hillhouse Capital, Tigermed, TF Capital, Tiger Yeah Capital, Sunmed Capital and so on.
Development History
R&D manufacture capacity and system construction
Construction of Quality System (ISO, GMP)
Construction of management and operation system
Core Team
An Liu
Founder, CEO
Shanghai, China
  • A serial entrepreneur achieves from 0 to 1, from 1 to more in many companies, and sets up and cultivates management team.
  • Established KAI MEDTECH INC to produce, develop and sell high-end interventional implantable medical devices in China and the United States (Shanghai, Hangzhou, California, USA), and obtained investment from well-known institutions such as Hillhouse Capital, Tigermed, TF Capital, Tiger Yeah Capital and Sunmed Capital.
  • Commercial negotiations won the rights and interests of the top American cerebrovascular intervention company in China, and the co-founder founded the sales platform of cerebrovascular interventional products in China.
  • General Manager of Asia Pacific Region of the largest and most professional medical device R&D outsourcing service company (testing, materials, preclinical, clinical, regulatory and quality system) in the world.
  • He performed life cycle management of medical devices and led FDA forensics of more than 10 products and projects, and NMPA forensics of more than 20 European and American products in China.
  • 10 years’ experience in American medical device industry+8 years’ experience in Chinese medical device industry.
Joshua Benjamin
CTO
California, USA
  • Senior R&D Director of Neurvana Medical, LLC., who led the design and development of intracranial vascular products, including the successful transfer and sale of intracranial aspiration catheters for US $16 million
  • R&D Director of Blockade Medical, LLC., who led the research and development of neuro-interventional products, and the company was successfully acquired by Balt for 40 million US dollars
  • R&D manager of MindFrame, Inc., Lead Engineer, the third employee, was responsible for the research and development of many products including guided catheter, balloon catheter, and mechanical thrombectomy. The company was successfully acquired by Covidien (now Medtronic) for 75 million US dollars
Wei Zhao
Director of Marketing and Sales
Beijing, China
  • She has 14 years of marketing experience and team management experience in medical industry
  • She has worked as an executive in many nerves interventional head companies and has a deep understanding of the industry
  • Work in the last domestic company, she led the marketing department to help the company complete the listing and promotion of many products. She cooperated with the company's future product line layout and BD development direction, and optimized the company's product line
  • In Kai MedTech, she will be responsible for marketing and sales, planning and expanding the development strategy of the enterprise, formulating and implementing the strategic development plan of the company
David Zarbatany
R&D Vice President of VentriMend Inc
California, USA
  • Focusing on structural cardiology, VentriMend Inc is another wholly owned subsidiary of KAI MEDTECH, newly established in the United States. Before joining Kai MEDTECH, David was once
  • Senior R&D Director of Direct Flow Medical Inc, Transcatheter Aortic Valve Replacement
  • Senior Engineering Director of Acutus Medical Inc, Mapping and Imaging Catheters for Atrial Fibrillation Diagnosis
  • Senior Product Development Director of Surgivision Corporation, Magnetic Resonance Imaging Guided Devices and Therapies
  • Chief Research Officer of MiCardia Corporation, Plasty Ring of Percutaneous Adjustable Loop
  • Senior R&D Manager of Edwards Lifesciences, Percutaneous Mitral Valve Repair
  • Project Coordinator of Boston Scientific, Aortic Abdominal Aortic Aneurysm (AAA) Stent Graft
  • Project Coordinator of Medtronic, Coronary Dilatation Catheter and Coronary Stent System
Chao XU
Director, International Business
Berlin, Germany
  • Ph.D in Medical Neurosciences, Berlin Charité
  • Over 10-year experiences in research, regulatory, clinical and business strategy of medical devices
  • Founded J MedTec Berlin GmbH and the Europe Branch of Osmunda Medical Device Service Group. Focused on market process and technology transfer of international innovative products in China and Asian-pacific regions, as well as international business development of Chinese medical companies.
  • China expert consultant for Medical Daily of Reuters, author of China Business Manual of Israel Export Institution, Lecturer of CAS program of FHNW University in Switzerland
  • Elite Overseas Manager in Delegate Enterprise Group met by Chinese Premier Li Keqiang (2014 & 2017)
Zhao Liang
Director of Strategy and Financing
Shanghai,China
  • Before joining KAI MEDTECH, Zhao was once
  • Vice President of Jiangsu Jinyangzi to manage the foreign investment
  • Project Manager of Pan-China Certified Public Accountants
  • Manager of Shanghai Citibank, VIP Branch
Enterprise Culture
Shanghai Kai Medtech Co., Ltd

3/F, Kechuang Building,
Building 1, Lianhang Road 1588, Minhang District, Shanghai

Tel：021-5223-7253
Mail：info@kaimtgroup.com
Hangzhou Kai Medtech Co., Ltd

5/F, Building 5, Wanlun Science and Technology Park, Jiangling Road 88, Binjiang District, Hangzhou City, Zhejiang Province

Tel：0571-85851949
Mail：info@kaimtgroup.com
KAI MEDTECH, LLC

22651 Lambert Street, Suite 107 Lake Forest, CA 92630, USA

Tel：+1 (949) 797-8960
Mail：info@kaimtgroup.com